Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
The Thomsen-Friedenreich (TF) antigen is expressed in a majority of human tumors due to aberrant glycosylation in cancer cells. There is strong evidence that humoral immune response to TF represents an effective mechanism for the elimination of cancer cells that express TF-positive glycoconjugates....
Main Author: | Oleg Kurtenkov |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/9747040 |
Similar Items
-
The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer
by: Oleg Kurtenkov, et al.
Published: (2018-01-01) -
Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer
by: Oleg Kurtenkov, et al.
Published: (2015-01-01) -
Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance
by: Oleg Kurtenkov, et al.
Published: (2017-01-01) -
Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential
by: Oleg Kurtenkov, et al.
Published: (2014-01-01) -
Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability
by: Beatriz Leão, et al.
Published: (2021-01-01)